Displaying 11 - 20 of 22
Childhood cancer survivor and family support Light the Night
Updated:
Ian Kirouac began fundraising for blood cancers through the Leukemia & Lymphoma Society of Canada's event, Light The Event, after his daughter was diagnosed with non-Hodgkins lymphoma.
Events, Media Mentions, Partners, Stories, Lymphoma
First ever Pediatrics Oncology Day at CANO 2023
Updated:
We were honoured to be invited to host CANO’s first ever Pediatrics Oncology Day on the Saturday (Oct. 21) and grateful for the incredible knowledge shared by our fellow presenters over almost an hour and a half.
Events, Partners, Pediatrics
Blood cancer research extended further with LLSC partnerships
Updated:
Beyond the scope of our research grant opportunities, LLSC is pleased to have other opportunities to partner in co-funding research with like-minded organizations.
Partners, Research
Myeloma Awareness Month: Dr. Hira Mian
Updated:
This being Myeloma Awareness Month in Canada, we thought we’d shine a light on one of this country’s leading researchers of myeloma – specifically, multiple myeloma.
Events, Partners, Research, Myeloma
Blood cancer quality of life research supported by Steele Auto Group
Updated:
Great research takes solid funding; The Leukemia & Lymphoma Society of Canada (LLSC) is fortunate to the support of Steele Auto Group (SAG) headquartered in Dartmouth, Nova Scotia.
Events, Partners, Research
LLSC’s first publication in a medical journal
Updated:
What an honour to be invited to publish in the Canadian Oncology Nursing Journal, and how exciting to see it in print in the Spring 2024 edition!
Media Mentions, Partners, Research
CAPO 2024 Psychosocial oncology networking
Updated:
LLSC Community Service Lead for Alberta, Desiree Naylor, recently attended the Canadian Association of Psychosocial Oncology (CAPO 2024) Conference – the first time the event has been held in Calgary in more than 20 years.
Events, Partners, Mental health and wellness
Spotlight on GvHD, a serious side effect of stem cell transplants
Updated:
Graft vs. Host Disease (GvHD) is a serious side effect that commonly affects people who've undergone an allogeneic stem cell transplant (SCT), meaning they've received stem cells to treat their blood cancer. LLSC presented at the International GvHD Symposium in October…
Events, Partners, Treatment and side effects
The Collings Stevens Family Foundation partners with LLSC to help Canadians impacted by CML
Updated:
The Leukemia & Lymphoma Society of Canada, with partners like The Collings Stevens Family Foundation, is informing and empowering people impacted by chronic myeloid leukemia (CML), a once-fatal blood cancer now a manageable disease.
Partners, Leukemia
New AI research award recipient supported by UFCW
Updated:
One of the exciting, novel aspects of LLSC’s latest blood cancer research awards is the introduction of the Artificial Intelligence (AI) Catalyst Grant, for the application of AI to blood cancer research.
Partners, Research